G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension

CONCLUSIONS: This study reveals that G6PD is an immune-related biomarker and a possible therapeutic target for LUAD and PAH patients.PMID:38194707 | DOI:10.18632/aging.205381

Source: Aging - January 9, 2024 Category: Biomedical Science Authors: Rongzhen Ding Shuliu Sang Jian Yi Haiping Xie Feiying Wang Aiguo Dai Source Type: research